Cargando…
Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus
Mycobacterium abscessus infections are difficult to treat and are often considered untreatable without tissue resection. Due to the intrinsic drug-resistant nature of the bacteria, combination therapy of three or more antibiotics is recommended. A major challenge in treating M. abscessus infections...
Autores principales: | Van, Nhi, Degefu, Yonatan N., Leus, Pathricia A., Larkins-Ford, Jonah, Klickstein, Jacob, Maurer, Florian P., Stone, David, Poonawala, Husain, Thorpe, Cheleste M., Smith, Trever C., Aldridge, Bree B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353461/ https://www.ncbi.nlm.nih.gov/pubmed/37278639 http://dx.doi.org/10.1128/aac.00090-23 |
Ejemplares similares
-
Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements
por: Larkins-Ford, Jonah, et al.
Publicado: (2022) -
Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis
por: Larkins-Ford, Jonah, et al.
Publicado: (2021) -
C25-modified rifamycin derivatives with improved activity against Mycobacterium abscessus
por: Paulowski, Laura, et al.
Publicado: (2022) -
Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination
por: Pryjma, Mark, et al.
Publicado: (2018) -
Epetraborole Is Active against Mycobacterium abscessus
por: Ganapathy, Uday S., et al.
Publicado: (2021)